Wednesday, October 17, 2018 1:18:22 PM
Dr.Pulinilkunnil knows very well the results of the Blood Storage. He would have read every research report available before he started plans for his own lab work. He has knowledge of the scientists who carried on the test in the past. If Dr. Pulinilkunnil did not trust past findings, he would not waste his time furthering the study of PKTX's PKX-100.
As each new scientist adds their research to the various studies, AAGP will be proven once again to work as a required ingredient in prolonging the life of cells in research projects.
It is just a matter of time PKTX investors. CSmith will make us all rich.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM